• 校内登录
访问量：   最后更新时间：--

赵四海

电子邮箱：
所在单位：基础医学院
职务：动物中心 书记/常务副主任
学历：博士研究生毕业
办公地点：1. 雁塔校区SPF楼2楼208
2. 创新港22号楼2楼S234
性别：男
联系方式：
学位：博士
职称：教授
博士生导师：是
硕士生导师：是
学科：基础医学
团队主要成员
当前位置： 中文主页 > 团队主要成员
所在课题组人员组成

 

实验室教师：

 

1，刘恩岐     教授     系主任

2，赵四海     教授     系副主任

3，武  一     教授    （青拔A）

4，郭  龙     教授    （青拔A）

5，白  亮     教授  

6，王维蓉     教授  

7，王  蓉     副教授

8，屈鹏祥     副教授（青秀A）

 

 

实验技术员：

薛莹、夏聪聪、孙珂欣、曹旭红、雷婷、朱虹、金昕、冯贞、车乐、段晨静、侯海雯

 

博士后：

冉林武

 

在读博士生：

郑华东、武敏、成大欣、杜红雁、吴璟、贾林莹、Naqash Alam、Nazira Fatima、陈力方、付裕、曹雯彬、刘浩乐、张艳茹、贺学、赵娟、魏盼盼、齐佳

 

在读硕士生：

刘懿、赵昱琦、秦龙龙、巴真真

 

在读留学生：

Fizza Malik

 

进修生：

付纬来（毕业）、李濛（毕业）、张桐赫

 

本科生：

路明（毕业）、阿卜杜凯尤木（毕业）、邹佳卫（毕业）、吴海滨（毕业）、田瑞浦、袁泉

 

毕业博士生：

赵四海、余琦、陈玉龙、李亚峰、林燕、王艳丽、关华、高守翠、刘宝宁、屈鹏祥、张光伟、张亚莉、于清清、李艳东

 

 毕业硕士生：

郑华东、杨佩刚、李亚峰、林燕、张春芳、程芳、朱宁红、安英风、黄炳俏、孙丽晶、王晓靖、徐丽然、张晨阳、Mahreen Fatima、丁新华、田康利、李可心

 

 

 

 

 

刘浩乐 博士生

image.png

         刘浩乐  

博士研究生（2021.09至        ）

        

发表论文：

  1.  Liu H#, Tian K#, Fu W#, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026;16(3): 101453.  # co-first authors.  IF=11.2  

  2.  Liu H, Zhang J, Xue Z, Chang M, Feng X, Cai Y, Bai L, Wang W, Liu E, Zhao S, Wang R. Deficiency of protein inhibitor of activated STAT3 exacerbates atherosclerosis by modulating VSMC phenotypic switching. Atherosclerosis. 2023;380:117195. IF=7.1

  3. Liu H#, Qin L#, Zou J, Tian K, Li K, Tian R, Malik F, Wei P, Xia C, Hou H, Cai T, Meng Y, Liu E, Xu B, Zhao S. Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm. Eur J Pharm Sci. 2025;211:107143. IF=5.1

  4. Liu H, Wei P, Fu W, Xia C, Li Y, Tian K, Li Y, Cheng D, Sun J, Xu Y, Lu M, Xu B, Zhang Y, Wang R, Wang W, Xu B, Liu E, Zhao S. Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxid Med Cell Longev. 2022;2022:8502059. IF=7.3

  5. Liu H, Tian K, Xia C, Wei P, Xu B, Fu W, Li Y, Li Y, Bai L, Wang R, Wang W, Xu B, Liu E, Zhao S. Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms. Animal Model Exp Med. 2022;5(1):72-80. IF=3.3

  6. Fu Y#, Liu H#, Li K, Wei P, Alam N, Deng J, Li M, Wu H, He X, Hou H, Xia C, Wang R, Wang W, Bai L, Xu B, Li Y, Wu Y, Liu E, Zhao S. C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms. Front Immunol. 2023;14:1233807.  IF=7.0

  7. Fu W#, Liu H#, Wei P, Xia C, Yu Q, Tian K, Li Y, Liu E, Xu B, Miyata M, Wang R, Zhao S. Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms. Front Cardiovasc Med. 2023;10:1092555.  IF=3.0

  8. Tian K, Tian R, Qin L, Liu H, Malik F, Wei P, Zou J, Li K, Hou H, Sun K, Wang R, Wang W, Bai L, Xu B, Liu E, Zhao S. Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms. Phytomedicine. 2025;147:157176.  IF=11.3

  9. Yu QQ, Cheng DX, Xu LR, Li YK, Zheng XY, Liu Y, Li YF, Liu HL, Bai L, Wang R, Fan JL, Liu EQ, Zhao SH. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits. Acta Pharmacol Sin. 2020;41(4):546-553.  IF=10.4

  10. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024:8826287.   IF=2.8

  11. Li M, Wei P, Li K, Liu H, Alam N, Hou H, Deng J, Xu B, Liu E, Zhao S, Li Y. The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice. Animal Model Exp Med. 2024;7(3):388-395.  IF=3.3

  12. Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, Lu M, Li Y, Li Y, Cheng D, Liu E, Zhao S. Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms. J Immunol Res. 2021:6297332.  IF=3.2

  13. Wei P, Tian K, Liu H, Li K, Alam N, Cheng D, Li M, He X, Guo J, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochim Biophys Acta Mol Basis Dis. 2024; 1870(5):167170.  IF=5.0

  14. Wei P, Li K, Li M, Liu H, Xia C, Chen Y, Zhao S, Li Y. The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm. Front Cardiovasc Med. 2024;11: 1462032. IF=3.0

  15. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023;24(4):3819.  IF=5.6

魏盼盼 博士生

1fc6bc79ea30043ea9d229a63b0d2c64_4123115031.jpg

     魏盼盼  

博士研究生（2023.09至        ）


发表论文与奖励：

  1. 瑞沃德奖学金 2022年度。

  2. Wei P# , Tian K# , Liu H, Li K, Alam N, Cheng D, Li M, He X, Guo J, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochim Biophys Acta Mol Basis Dis. 2024; 1870(5):167170.  # co-first authors. IF=5.0

  3. Wei P, Li K, Li M, Liu H, Xia C, Chen Y, Zhao S, Li Y. The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm. Front Cardiovasc Med. 2024;11: 1462032. IF=3.0

  4. Liu H, Wei P, Fu W, Xia C, Li Y, Tian K, Li Y, Cheng D, Sun J, Xu Y, Lu M, Xu B, Zhang Y, Wang R, Wang W, Xu B, Liu E, Zhao S. Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxid Med Cell Longev. 2022:8502059. IF=7.3

  5. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023;24(4):3819.  IF=5.6

  6. Li M, Wei P, Li K, Liu H, Alam N, Hou H, Deng J, Xu B, Liu E, Zhao S, Li Y. The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice. Animal Model Exp Med. 2024;7(3):388-395.  IF=3.3

  7. Liu H, Tian K, Fu W, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026; 16(3):101453.  IF=11.2

  8. Tian K, Tian R, Qin L, Liu H, Malik F, Wei P, Zou J, Li K, Hou H, Sun K, Wang R, Wang W, Bai L, Xu B, Liu E, Zhao S. Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms. Phytomedicine. 2025;147:157176.  IF=11.3

  9. Liu H, Qin L, Zou J, Tian K, Li K, Tian R, Malik F, Wei P, Xia C, Hou H, Cai T, Meng Y, Liu E, Xu B, Zhao S. Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm. Eur J Pharm Sci. 2025;211:107143. IF=5.1

  10. Liu H, Tian K, Xia C, Wei P, Xu B, Fu W, Li Y, Li Y, Bai L, Wang R, Wang W, Xu B, Liu E, Zhao S. Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms. Animal Model Exp Med. 2022;5(1):72-80. IF=3.3

  11. Fu Y#, Liu H#, Li K, Wei P, Alam N, Deng J, Li M, Wu H, He X, Hou H, Xia C, Wang R, Wang W, Bai L, Xu B, Li Y, Wu Y, Liu E, Zhao S. C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms. Front Immunol. 2023;14:1233807.  IF=7.0

  12. Fu W#, Liu H#, Wei P, Xia C, Yu Q, Tian K, Li Y, Liu E, Xu B, Miyata M, Wang R, Zhao S. Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms. Front Cardiovasc Med. 2023;10:1092555.  IF=3.0

  13. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024:8826287.   IF=2.8

  14. Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, Lu M, Li Y, Li Y, Cheng D, Liu E, Zhao S. Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms. J Immunol Res. 2021:6297332.  IF=3.2


李可心 硕士生

{AE272ABE-95D4-456D-B2E1-029DE9C00CD6}.png

      李可心  

硕士士研究生（2023.09至        ）


发表论文与奖励：

  1. 国家奖学金 2025年度。

  2. 国家奖学金 2024年度。

  3. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024 Nov 27;2024:8826287.   IF=2.8

  4. Wei P, Li K, Li M, Liu H, Xia C, Chen Y, Zhao S, Li Y. The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm. Front Cardiovasc Med. 2024 Sep 27;11:1462032. IF=3.0

  5. Wei P, Tian K, Liu H, Li K, Alam N, Cheng D, Li M, He X, Guo J, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167170.  IF=5.0

  6. Li M, Wei P, Li K, Liu H, Alam N, Hou H, Deng J, Xu B, Liu E, Zhao S, Li Y. The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice. Animal Model Exp Med. 2024 Jun;7(3):388-395.  IF=3.3

  7. Liu H, Tian K, Fu W, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026 Mar;16(3):101453.  IF=11.2

  8. Tian K, Tian R, Qin L, Liu H, Malik F, Wei P, Zou J, Li K, Hou H, Sun K, Wang R, Wang W, Bai L, Xu B, Liu E, Zhao S. Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms. Phytomedicine. 2025 Nov;147:157176.  IF=11.3

  9. Liu H, Qin L, Zou J, Tian K, Li K, Tian R, Malik F, Wei P, Xia C, Hou H, Cai T, Meng Y, Liu E, Xu B, Zhao S. Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm. Eur J Pharm Sci. 2025 Aug 1;211:107143. IF=5.1

  10. Fu Y#, Liu H#, Li K, Wei P, Alam N, Deng J, Li M, Wu H, He X, Hou H, Xia C, Wang R, Wang W, Bai L, Xu B, Li Y, Wu Y, Liu E, Zhao S. C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms. Front Immunol. 2023 Sep 11;14:1233807.  # co-first authors. IF=7.0


秦龙龙 硕士生

60bc39ebb739d4c127539c383b65a964_3124115042.jpg

      秦龙龙  

硕士士研究生（2024.09至        ）


发表论文与奖励：

  1. 国家奖学金 2025年度。

  2. Liu H#, Qin L#, Zou J, Tian K, Li K, Tian R, Malik F, Wei P, Xia C, Hou H, Cai T, Meng Y, Liu E, Xu B, Zhao S. Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm. Eur J Pharm Sci. 2025;211:107143. # co-first authors. IF=5.1

  3. Liu H, Tian K, Fu W, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026;16(3): 101453.  IF=11.2

  4. Tian K, Tian R, Qin L, Liu H, Malik F, Wei P, Zou J, Li K, Hou H, Sun K, Wang R, Wang W, Bai L, Xu B, Liu E, Zhao S. Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms. Phytomedicine. 2025;147:157176.  IF=11.3


张桐赫 硕士生

3bb0bac4095679a6e84efbbd61247f93.jpg

      张桐赫  

硕士研究生（2024.09至       ）

     和李艳奎教授联合培养

        

发表论文：

  1. Li Z, Zhang T, Zhu G, Shen H, Zhang M, Wang H, Yang H, Hu H, Li Y. Risk stratification of in-hospital venous thromboembolism for urological cancers: a multicenter retrospective study. Ther Adv Med Oncol. 2026;18:17588359261430135.  IF=4.1

  2. Chen B, Zhang T, Wang Y, Li Z, Liu H, Jiang Z, Yang H, Cai Y, Fan G, Wang K, Zhang H, Hu H, Li Y. Elevated C-reactive protein and D-dimer to predict venous thromboembolism in patients with bladder cancer. Front Immunol. 2025;16:1652139.  IF=7.0

  3. Wang K, Zhang L, Li Q, Wang Q, Jiang Z, Wei Y, Zhang T, Li Z, Jiang Z, Yang H, Cai Y, Fan G, Chen B, Zhang H, Li Y, Sun J. Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic pancreatic cancer. Clin Transl Oncol. 2025;27(12):4466-4480. IF=2.7

  4. Yang H, Zhang T, Li Z, Cai Y, Jiang Z, Fan G, Wang K, Chen B, Zhang H, Hu H, Li Y. Risk factors for in-hospital venous thromboembolism in patients with bladder cancer: A retrospective single-center study. BMC Cancer. 2025;25(1):536. IF=4.1

  5. Li Z, Yang L, Yang H, Zhang T, Cai Y, Jiang Z, Fan G, Wang K, Chen B, Zhang H, Hu H, Li Y. Comparison of Superselective Renal Artery Embolization versus Retroperitoneal Laparoscopic Partial Nephrectomy in Ruptured Hemorrhagic Renal Angiomyolipoma: A Single-Center Study. Diseases. 2024;12(9):218.   IF=3.7



于清清 毕业博士生

 b218fc890fe2766e5044962ecbd21605_4118015010.jpg

      于清清 

博士研究生（2018.09至2023.06）

（毕业后在徐州医科大学工作）

        

发表论文：

  1. Yu Q#, Cheng D#, Xu L, Li Y, Zheng X, Liu Y, Li Y, Liu H, Bai L, Wang R, Fan J, Liu E, Zhao S. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits. Acta Pharmacol Sin. 2020;41(4):546-553. # co-first authors.  IF=10.4

  2. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023;24(4):3819.  IF=5.6

  3. Yu Q, Tian K, Fatima N, Zhao S. Diabetic status aggravates atherosclerosis in aged ApoE-/- mice. Animal Model Exp Med. 2024;7(6):964-965.   IF=3.3

  4. Fu W#, Liu H#, Wei P, Xia C, Yu Q, Tian K, Li Y, Liu E, Xu B, Miyata M, Wang R, Zhao S. Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms. Front Cardiovasc Med. 2023;10:1092555.  IF=3.0

  5. Liu B, Bai L, Yu Q, Hu F, Wu J, Zhao S, Wang R, Wang W, Tao Y, Fan J, Liu E. iMarmot: an integrative platform for comparative and functional genomics of marmots. BMC Genomics. 2020;21(1): 266.  IF=3.9

  6. Gao S, Xu L, Zhang Y, Yu Q, Li J, Guan H, Wang X, Cheng D, Liu Y, Bai L, Wang R, Fan J, Zhao S, Liu E. Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling. Cell Physiol Biochem. 2018;50(5):1740-1753.  IF=5.5


田康利 毕业硕士生

a7a92c875a960c23f821cca210e4b5cd_3120115044.jpg

     田康利  

硕士毕业生（2020.09至2023.06）

访问学者（2024.09至2025.02）

        

发表论文：

  1. Tian K, Tian R, Qin L, Liu H, Malik F, Wei P, Zou J, Li K, Hou H, Sun K, Wang R, Wang W, Bai L, Xu B, Liu E, Zhao S. Animal studies and AI-based analysis identify the efficacy of berberine to inhibit experimental abdominal aortic aneurysms. Phytomedicine. 2025;147:157176.  IF=11.3

  2. Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, Lu M, Li Y, Li Y, Cheng D, Liu E, Zhao S. Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms. J Immunol Res. 2021:6297332.  IF=3.2

  3. Tian K, Malik F, Zhao S. Animal models for abdominal aortic aneurysms: Where we are and where we need to go. Animal Model Exp Med. 2025;8(3):573-577.  IF=3.3

  4. Liu H#, Tian K#, Fu W#, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026;16(3): 101453.  # co-first authors.  IF=11.2  

  5. Wei P#, Tian K#, Liu H, Li K, Alam N, Cheng D, Li M, He X, Guo J, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167170.  IF=5.0

  6. Yu Q, Tian K, Fatima N, Zhao S. Diabetic status aggravates atherosclerosis in aged ApoE-/- mice. Animal Model Exp Med. 2024;7(6):964-965.  IF=3.3

  7. Liu H, Tian K, Xia C, Wei P, Xu B, Fu W, Li Y, Li Y, Bai L, Wang R, Wang W, Xu B, Liu E, Zhao S. Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms. Animal Model Exp Med. 2022;5(1):72-80. IF=3.3

  8. Liu H#, Qin L#, Zou J, Tian K, Li K, Tian R, Malik F, Wei P, Xia C, Hou H, Cai T, Meng Y, Liu E, Xu B, Zhao S. Intra-aortic infusion of nicotine can induce a novel mouse model of abdominal aortic aneurysm. Eur J Pharm Sci. 2025;211:107143. IF=5.1

  9. Liu H, Wei P, Fu W, Xia C, Li Y, Tian K, Li Y, Cheng D, Sun J, Xu Y, Lu M, Xu B, Zhang Y, Wang R, Wang W, Xu B, Liu E, Zhao S. Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxid Med Cell Longev. 2022:8502059. IF=7.3

  10. Fu W#, Liu H#, Wei P, Xia C, Yu Q, Tian K, Li Y, Liu E, Xu B, Miyata M, Wang R, Zhao S. Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms. Front Cardiovasc Med. 2023;10:1092555.  IF=3.0

  11. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024:8826287.   IF=2.8

  12. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023;24(4):3819.  IF=5.6


付纬来 毕业硕士生

{BF707A91-B20B-4E36-A8B3-076069467D65}.png

       付纬来  

硕士研究生（2020.09至2023.06）

     和李艳奎教授联合培养

        

发表论文：

  1. Fu W#, Liu H#, Wei P, Xia C, Yu Q, Tian K, Li Y, Liu E, Xu B, Miyata M, Wang R, Zhao S. Genetic deficiency of protein inhibitor of activated STAT3 suppresses experimental abdominal aortic aneurysms. Front Cardiovasc Med. 2023 Mar 15;10:1092555.  # co-first authors. IF=3.0

  2.  Liu H#, Tian K#, Fu W#, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026 Mar;16(3):101453.  IF=11.2

  3. Liu H, Wei P, Fu W, Xia C, Li Y, Tian K, Li Y, Cheng D, Sun J, Xu Y, Lu M, Xu B, Zhang Y, Wang R, Wang W, Xu B, Liu E, Zhao S. Dapagliflozin Ameliorates the Formation and Progression of Experimental Abdominal Aortic Aneurysms by Reducing Aortic Inflammation in Mice. Oxid Med Cell Longev. 2022 Jan 28;2022:8502059. IF=7.3

  4. Liu H, Tian K, Xia C, Wei P, Xu B, Fu W, Li Y, Li Y, Bai L, Wang R, Wang W, Xu B, Liu E, Zhao S. Kunming mouse strain is less susceptible to elastase-induced abdominal aortic aneurysms. Animal Model Exp Med. 2022 Feb;5(1):72-80. IF=3.3

  5. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024 Nov 27;2024:8826287.   IF=2.8

  6. Tian K, Xia C, Liu H, Xu B, Wei P, Fu W, Lu M, Li Y, Li Y, Cheng D, Liu E, Zhao S. Temporal and Quantitative Analysis of Aortic Immunopathologies in Elastase-Induced Mouse Abdominal Aortic Aneurysms. J Immunol Res. 2021 Nov 16;2021:6297332.  IF=3.2

  7. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023 Feb 14;24(4):3819.  IF=5.6


李濛 毕业硕士生

3c6a782ff171a173b7a0e894b707569.jpg

    李 濛 

硕士毕业研究生（2021.09至 2024.06 ）

           和李艳奎教授联合培养

        

发表论文：

  1. Li M, Wei P, Li K, Liu H, Alam N, Hou H, Deng J, Xu B, Liu E, Zhao S, Li Y. The incidence rate and histological characteristics of intimal hyperplasia in elastase-induced experimental abdominal aortic aneurysms in mice. Animal Model Exp Med. 2024 Jun;7(3):388-395.  IF=3.3

  2. Liu H, Tian K, Fu W, Qin L, Tian R, Wei P, Zou J, Alam N, Malik F, Li K, Li M, Xu B, Guo J, Xia C, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. J Pharm Anal. 2026 Mar;16(3):101453.  IF=11.2

  3. Fu Y#, Liu H#, Li K, Wei P, Alam N, Deng J, Li M, Wu H, He X, Hou H, Xia C, Wang R, Wang W, Bai L, Xu B, Li Y, Wu Y, Liu E, Zhao S. C-reactive protein deficiency ameliorates experimental abdominal aortic aneurysms. Front Immunol. 2023 Sep 11;14:1233807.  # co-first authors. IF=7.0

  4. Li K, Li M, Wei P, Tian K, Liu H, Fu W, Hou H, Chen Y, Xu B, Li Y, Zhao S. Cysteine Leukotriene Receptor Antagonist-Montelukast-Treatment Improves Experimental Abdominal Aortic Aneurysms in Mice. Cardiovasc Ther. 2024 Nov 27;2024:8826287.   IF=2.8

  5. Wei P, Tian K, Liu H, Li K, Alam N, Cheng D, Li M, He X, Guo J, Wang R, Wang W, Bai L, Liu E, Xu B, Li Y, Zhao S. Urotensin II receptor deficiency ameliorates ligation-induced carotid intimal hyperplasia partially through the RhoA-YAP1 pathway. Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167170.  IF=5.0

  6. Wei P, Li K, Li M, Liu H, Xia C, Chen Y, Zhao S, Li Y. The C57BL/6N mouse substrain is a viable model of elastase-induced abdominal aortic aneurysm. Front Cardiovasc Med. 2024 Sep 27;11:1462032. IF=3.0


徐丽然 毕业硕士生

b157bfed966c301d3201fc07b2be03f1_3115115008.jpg 

    徐丽然 

硕士研究生（2015.09至2018.06）

（博士毕业后在西交大一附院工作）

        

发表论文：

  1. Yu Q#, Cheng D#, Xu L, Li Y, Zheng X, Liu Y, Li Y, Liu H, Bai L, Wang R, Fan J, Liu E, Zhao S. Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits. Acta Pharmacol Sin. 2020 Apr;41(4):546-553. # co-first authors.  IF=10.4

  2. Yu Q, Wei P, Xu L, Xia C, Li Y, Liu H, Song X, Tian K, Fu W, Wang R, Wang W, Bai L, Fan J, Liu E, Zhao S. Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits. Int J Mol Sci. 2023 Feb 14;24(4):3819.  IF=5.6

  3. Gao S, Xu L, Zhang Y, Yu Q, Li J, Guan H, Wang X, Cheng D, Liu Y, Bai L, Wang R, Fan J, Zhao S, Liu E. Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling. Cell Physiol Biochem. 2018;50(5):1740-1753.  IF=5.5

  4. Wang R, Yang L, Zhang Y, Li J, Xu L, Xiao Y, Zhang Q, Bai L, Zhao S, Liu E, Zhang YJ. Porcine reproductive and respiratory syndrome virus induces HMGB1 secretion via activating PKC-delta to trigger inflammatory response. Virology. 2018 May;518:172-183. 

  5. Wang R, Zhang Y, Xu L, Lin Y, Yang X, Bai L, Chen Y, Zhao S, Fan J, Cheng X, Liu E. Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice. Sci Rep. 2016 Nov 15;6:36790.



安英风 毕业硕士生

        安英风 

硕士研究生（2012.09至2015.06）

        

发表论文：

  1. An Y, Gao S, Cheng D, Wang X, Bai L, Liu E, Chu Y, Zhao S. Peginterferon and Chinese herbs exert a combinatorial effect in HBeAg-positive chronic hepatitis B. J Infect Dev Ctries. 2016 Apr 28;10(4):369-76.  IF=1.3

  2. Li Y, Gao S, An Y, Liu E, Zhao S. High dose atorvastatin therapy yields a better carotid atherosclerosis improvement in Chinese patients. Int J Cardiol. 2015;185:131-2. IF=3.3

  3. Guan H, Lin Y, Bai L, An Y, Shang J, Wang Z, Zhao S, Fan J, Liu E. Dietary Cocoa Powder Improves Hyperlipidemia and Reduces Atherosclerosis in apoE Deficient Mice through the Inhibition of Hepatic Endoplasmic Reticulum Stress. Mediators Inflamm. 2016;2016:1937572. IF=4.9

  4. Liu B, Zhang Y, Wang R, An Y, Gao W, Bai L, Li Y, Zhao S, Fan J, Liu E. Western diet feeding influences gut microbiota profiles in apoE knockout mice. Lipids Health Dis. 2018;17(1):159.  IF=6.9



版权所有：西安交通大学 陕ICP备05001571号